Haemaccel (3.5% isocyanate crosslinked polypeptide solution) effectively increased intravascular volume in patients with gastro-intestinal bleeding. This study found no undesirable side effects, indicating its safety for shock treatment and prophylaxis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: